Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
McDowell v. Eli Lilly and Company
Case Number:
1:13-cv-03786
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 26, 2015
NY Federal Court Won't Rethink Cymbalta Labeling Suit
A New York federal judge on Thursday declined to review a suit against Eli Lilly & Co. over the labeling of its antidepressant Cymbalta that allegedly downplays its withdrawal symptoms, finding that the plaintiff had not introduced any new evidence that warranted a new look at the case.
-
December 10, 2014
JPML Refuses To Consolidate Cymbalta Cases
The U.S. Judicial Panel on Multidistrict Litigation on Wednesday rejected a bid by plaintiffs to consolidate more than two dozen suits over Eli Lilly & Co.'s antidepressant Cymbalta, which they claim causes serious health problems the drugmaker misled consumers about.
-
November 07, 2014
Lilly Defeats Cymbalta Label Suit As Possible MDL Looms
A New York federal judge on Friday ruled Eli Lilly & Co.'s label for antidepressant drug Cymbalta adequately warned doctors about possible withdrawal symptoms and tossed a suit claiming the label was inaccurate, potentially hurting the plaintiffs' chances to consolidate more than two dozen similar cases in multidistrict litigation.
-
September 18, 2014
Eli Lilly Slams NY Cymbalta Suit As Possible MDL Looms
Eli Lilly & Co. on Wednesday sought early dismissal of a suit alleging it failed to warn a New York man he would suffer negative withdrawal effects when he stopped taking the antidepressant Cymbalta, hoping to moot more than two dozen similar cases in proposed multidistrict litigation.